SCHEMBL13507561

SCHEMBL13507561

Cn1c2cc(N(c3ccccc3)c3ccc4ccccc4c3)ccc2c2c3ccc4c(c3ccc21)c1ccc(N(c2ccccc2)c2ccc3ccccc3c2)cc1n4C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NQO2 P16083 1/20 0.33
▸ KDM4E B2RXH2 6/20 0.33
▸ ALDH1A1 P00352 7/20 0.32
▸ LMNA P02545 3/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ TOP2A P11388 1/20 0.32
▸ PER2 O15055 1/20 0.31
▸ CRY1 Q16526 1/20 0.31
▸ CRY2 Q49AN0 1/20 0.31
▸ MAPT P10636 3/20 0.31
▸ L3MBTL1 Q9Y468 3/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ HPGD P15428 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13506985 0.96 NQO2 (0.35) NQO2KDM4EALDH1A1LMNAMEN1
SCHEMBL18565012 0.95 NQO2 (0.35) NQO2KDM4EALDH1A1MEN1KMT2A
SCHEMBL13507586 0.92 HTR1D (0.36) LMNA
SCHEMBL13506824 0.92 NQO2 (0.38) NQO2KDM4EALDH1A1LMNAMEN1
SCHEMBL18564817 0.90 NQO2 (0.37) NQO2KDM4EALDH1A1TOP2AMAPT
SCHEMBL13507767 0.88 KDM4E (0.37) KDM4EALDH1A1LMNATOP2APER2
SCHEMBL18565011 0.88 RXRA (0.39) NQO2PER2CRY1CRY2L3MBTL1
SCHEMBL18565009 0.88 RXRA (0.39) NQO2PER2CRY1CRY2L3MBTL1
SCHEMBL18565010 0.87 KDM4E (0.36) KDM4EALDH1A1LMNAMEN1KMT2A
SCHEMBL18564994 0.86 GPR3 (0.46) KDM4EALDH1A1LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 NQO2 768/4885KDM4E 3009/4885ALDH1A1 119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback